Ticker League

EBITDA for Incyte (INCY)

Latest filings through · Reported

Metric

TTM

$1.87B

YoY change

+331.2%

5Y CAGR

—

Peak year (2025)

$1.76B

EBITDA history chart for Incyte (INCY) from 1993 to 2025

Latest: $1.76B

EBITDA growth chart for Incyte (INCY) from 1993 to 2025

Latest: +331.2%

EBITDA history table for Incyte (INCY) from 1993 to 2025

  • 2025$1.76B+331.2%
  • 2024$408.16M-55.6%
  • 2023$919.43M+53.3%
  • 2022$599.64M-4.8%
  • 2021$630.20M-453.6%
  • 2020−$178.24M-132.8%
  • 2019$543.18M+216.1%
  • 2018$171.86M-167.9%
  • 2017−$253.21M-223.8%
  • 2016$204.57M+108.7%
  • 2015$98.04M+147.0%
  • 2014$39.69M-364.8%
  • 2013−$14.99M-147.0%
  • 2012$31.89M-127.6%
  • 2011−$115.73M-421.8%
  • 2010$35.96M-129.2%
  • 2009−$123.08M-15.8%
  • 2008−$146.22M+102.2%
  • 2007−$72.32M+4.1%
  • 2006−$69.45M-25.0%
  • 2005−$92.59M-31.4%
  • 2004−$134.94M+37.0%
  • 2003−$98.50M-10.9%
  • 2002−$110.52M+548.8%
  • 2001−$17.03M-38.6%
  • 2000−$27.75M+1106.4%
  • 1999−$2.30M-107.7%
  • 1998$30.00M+111.3%
  • 1997$14.20M-691.7%
  • 1996−$2.40M-70.4%
  • 1995−$8.10M-27.7%
  • 1994−$11.20M+148.9%
  • 1993−$4.50M—

EBITDA values are taken from Incyte's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

About EBITDA at Incyte (INCY)

According to Incyte's latest reported financial statements, the company's current EBITDA (TTM) is $1.87B. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a common proxy for operating cash generation that strips out non-cash charges (depreciation and amortization) and capital structure effects (interest, taxes). Useful for comparing companies with different leverage and asset bases — see operating income and net income for fully GAAP figures.

Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .

As of the 2025 fiscal year, Incyte (INCY) reported EBITDA of $1.76B – surged 331.2% year-over-year.

Through 2015–2025 (10 years), Incyte EBITDA delivered a +33.5% annualised rate; with mixed annual results across the window.

The highest annual EBITDA of $1.76B was reported in 2025. The lowest in the available history was −$253.21M in 2017.

Incyte EBITDA by Year

Incyte EBITDA 2025: $1.76B

Incyte posted EBITDA of $1.76B in 2025, surged 331.2% from 2024. This figure represents the highest annual value in the available history.

Incyte EBITDA 2024: $408.16M

In 2024, Incyte reported EBITDA of $408.16M, plunged 55.6% below 2023.

Incyte EBITDA 2023: $919.43M

Incyte EBITDA in 2023 was $919.43M, surged 53.3% from 2022.

Incyte EBITDA 2022: $599.64M

2022's EBITDA for Incyte came in at $599.64M, edged down 4.8% below 2021.

Incyte EBITDA 2021: $630.20M

Incyte EBITDA in 2021 was $630.20M.

See more financial history for Incyte (INCY).

Sector peers by EBITDA

Healthcare peers of Incyte (INCY), ranked by their latest EBITDA

Frequently asked questions

Incyte (INCY) Key Financials

Charts, filings, and peer comparison for every metric

Explore more

Deep-dives across the income statement, cash flow, capital return, and valuation